Bipolar disorder
107 results
1 - 100
Family interventions for bipolar disorder- Tiagabine in the maintenance treatment of bipolar disorder
- Oxcarbazepine in the maintenance treatment of bipolar disorder
- Lamotrigine in the maintenance treatment of bipolar disorder
- Medicines for bipolar disorder in older people
- Tiagabine for acute affective episodes in bipolar disorder
- Interventions for the management of obesity in people with bipolar disorder
- Omega‐3 fatty acids for bipolar disorder
- Risperidone in long‐term treatment for bipolar disorder
- Oxcarbazepine for acute affective episodes in bipolar disorder
- Olanzapine in long‐term treatment for bipolar disorder
- Electroconvulsive therapy for preventing relapse and recurrence in bipolar disorder
- Topiramate for acute affective episodes in bipolar disorder in adults
- Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
- Interventions for helping people recognise early signs of recurrence in bipolar disorder
- Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder
- Electroconvulsive therapy for acute affective episodes in people with bipolar disorder
- Factors that influence participation in physical activity for people with bipolar disorder: a synthesis of qualitative evidence
- Lithium for maintenance treatment of mood disorders
- Lithium for acute mania
- Valproate for acute mania
- Inositol for depressive disorders
- Lithium versus antidepressants in the long‐term treatment of unipolar affective disorder
- Antiglucocorticoid and related treatments for psychosis
- Aripiprazole alone or in combination for acute mania
- Consultation liaison in primary care for people with mental disorders
- First rank symptoms for schizophrenia
- Pharmacological intervention for irritability, aggression, and self‐injury in autism spectrum disorder (ASD)
- Hemodialysis for lithium poisoning
- Antenatal psychosocial assessment for reducing perinatal mental health morbidity
- Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses
- Interventions to encourage uptake of cancer screening for people with severe mental illness
- Aripiprazole for autism spectrum disorders (ASD)
- Valproate for schizophrenia
- Lithium for schizophrenia
- Azapirones versus placebo for panic disorder in adults
- Voxel‐based morphometry for separation of schizophrenia from other types of psychosis in first episode psychosis
- Haloperidol alone or in combination for acute mania
- Olanzapine alone or in combination for acute mania
- Pharmacotherapies for cannabis use disorder
- Dissection versus diathermy for tonsillectomy
- Baclofen for alcohol use disorder
- User‐held personalised information for routine care of people with severe mental illness
- Carbamazepine for schizophrenia
- Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents
- Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries
- Shared decision‐making interventions for people with mental health conditions
- Dietary supplements for preventing postnatal depression
- Treatment for postpolio syndrome
- Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia
- Compulsory community and involuntary outpatient treatment for people with severe mental disorders
- Interventions for obtaining and maintaining employment in adults with severe mental illness, a network meta‐analysis
- Psychosocial interventions for people with both severe mental illness and substance misuse
- Pharmacological interventions for the treatment of disordered and problem gambling
- Collaborative care approaches for people with severe mental illness